E-resources
Peer reviewed
-
Palanques-Pastor, Tomás; Megías-Vericat, Juan Eduardo; Martínez, Pilar; López Lorenzo, José Luis; Cornago Navascués, Javier; Rodriguez Macias, Gabriela; Cano, Isabel; Arnan Sangerman, Montserrat; Vidriales Vicente, María Belén; Algarra Algarra, Jesús Lorenzo; Foncillas, María Ángeles; Herrera, Pilar; Botella Prieto, Carmen; Vives, Susana; Figuera Álvarez, Ángela; Cuevas Palomares, Laida; Sobas, Marta; Contento Gonzalo, Alejandro; Cuello García, Rebeca; Amutio Diez, María Elena; De Miguel Llorente, Dunia; Navas Elorza, Begoña; Bergua Burgues, Juan Miguel; Bernal Del Castillo, Teresa; Mateos Rodríguez, María Carmen; de Cabo López, Erik; Franco Villegas, Ana Carolina; García Boyero, Raimundo; Escolano Escobar, Cristian; Seri Merino, Cristina; Cervero, Carlos; Roldán Pérez, Alicia; Hermosín Ramos, Lourdes; Cervera Calvo, Marta; Olave, María Telesa; Villafuerte Gutiérrez, Paola; de Laiglesiai, Almudena; Serrano, Josefina; Najera Irazu, María Josefa; Piñana, José Luis; Sanz, Miguel Ángel; Martínez-López, Joaquín; Montesinos, Pau
Leukemia & lymphoma, 10/2021, Volume: 62, Issue: 12Journal Article
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces higher morbidity and mortality in hematological malignancies, but evidence in acute myeloid leukemia (AML) is scarce. A multicenter observational study was conducted to determine the clinical outcomes and assess the impact of therapeutic approaches in adult AML patients with SARS-CoV-2 infection in the first wave (March-May 2020). Overall, 108 patients were included: 51.9% with active leukemia and 70.4% under therapeutic schedules for AML. Signs and symptoms of SARS-CoV-2 were present in 96.3% of patients and 82.4% received specific treatment for SARS-CoV-2. The mortality rate was 43.5% and was correlated with age, gender, active leukemia, dyspnea, severe SARS-CoV-2, intensive care measures, neutrophil count, and D-dimer levels. A protective effect was found with azithromycin, lopinavir/ritonavir, and normal liver enzyme levels. During the SARS-CoV-2 first wave, our findings suggested an increased mortality in AML in a short period. SARS-CoV-2 management could be guided by risk factors in AML patients.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.